Background Health technology assessment (HTA) is a valuable tool for informing the efficient allocation of resources in ...

TL;DR: OpenAI’s new o1 model marks a significant leap in AI reasoning capabilities but introduces critical risks. Its reluctance to acknowledge mistakes, gaps in common-sense reasoning ...

Hopefully, the approval will help prevent shortages triggered by demand for injectable weight loss drugs such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) There is still no ...

This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the ...

Iilun Murphy, the director of the Office of Generic Drugs in the FDA’s Center for Drug Evaluation and Research, said in a statement. It may take a few more manufacturers bringing generics to the ...

In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday approved a second generic in the category of medications known as GLP-1s.

Scientific model of the molecule semaglutide which is the active ingredient in Novo Nordisk’s mega-blockbuster diabetes drug. REUTERS The agency said it prioritizes review of generic versions of ...

Dec 23 (Reuters) - The U.S. Food and Drug Administration on Monday approved Hikma Pharmaceuticals' (HIK.L), opens new tab generic version of Novo Nordisk's diabetes drug (NOVOb.CO), opens new tab ...

Google has released what it’s calling a new “reasoning” AI model — but it’s in the experimental stages, and from our brief testing, there’s certainly room for improvement. The new ...

If you're looking to buy one of the most popular EVs, then you'll want to see which year is the best for the Tesla Model 3. In compiling this article, we have cross-referenced information for ...